{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T03:48:58Z","timestamp":1795146538901,"version":"4.10.3"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82088102"],"award-info":[{"award-number":["82088102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271669"],"award-info":[{"award-number":["82271669"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82192864"],"award-info":[{"award-number":["82192864"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-026-01625-6","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:29:49Z","timestamp":1792150189000},"page":"2281-2300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["NNMT enhances hyperandrogenism in polyendocrine metabolic ovarian syndrome through epigenetic remodelling"],"prefix":"10.1038","volume":"8","author":[{"given":"Weiwei","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6071-7669","authenticated-orcid":false,"given":"Chuanjin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-3970","authenticated-orcid":false,"given":"Yishu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningxia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiting","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7125-9608","authenticated-orcid":false,"given":"Jiexue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2525-9462","authenticated-orcid":false,"given":"Hongbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-985X","authenticated-orcid":false,"given":"Hefeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"1625_CR1","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E. & Yildiz, B. O. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. 31, 2841\u20132855 https:\/\/doi.org\/10.1093\/humrep\/dew218 (2016).","journal-title":"Hum. Reprod."},{"key":"1625_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci, N. & Yildiz, B. O. Polycystic ovary syndrome as a metabolic disease. Nat. Rev. Endocrinol. 21, 230\u2013244 https:\/\/doi.org\/10.1038\/s41574-024-01057-w (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1625_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva, D. et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil. Steril. 106, 6\u201315 https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003 (2016).","journal-title":"Fertil. Steril."},{"key":"1625_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede, H., Deeks, A. & Moran, L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 8, 41 https:\/\/doi.org\/10.1186\/1741-7015-8-41 (2010).","journal-title":"BMC Med."},{"key":"1625_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz, R. et al. Polycystic ovary syndrome. Nat. Rev. Dis. Primers 2, 16057 https:\/\/doi.org\/10.1038\/nrdp.2016.57 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1625_CR6","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede, H. J. et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur. J. Endocrinol. 189, G43\u2013G64 https:\/\/doi.org\/10.1093\/ejendo\/lvad096 (2023).","journal-title":"Eur. J. Endocrinol."},{"key":"1625_CR7","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","volume":"407","author":"HJ Teede","year":"2026","unstructured":"Teede, H. J. et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet 407, 2329\u20132339 https:\/\/doi.org\/10.1016\/S0140-6736(26)00717-8 (2026).","journal-title":"Lancet"},{"key":"1625_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield, R. L. & Ehrmann, D. A. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of pcos as functional ovarian hyperandrogenism revisited. Endocr. Rev. 37, 467\u2013520 https:\/\/doi.org\/10.1210\/er.2015-1104 (2016).","journal-title":"Endocr. Rev."},{"key":"1625_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng, X., Xie, Y. J., Liu, Y. T., Long, S. L. & Mo, Z. C. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin. Chim. Acta 502, 214\u2013221 https:\/\/doi.org\/10.1016\/j.cca.2019.11.003 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"1625_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0657-6","volume":"11","author":"P Sagvekar","year":"2019","unstructured":"Sagvekar, P., Kumar, P., Mangoli, V., Desai, S. & Mukherjee, S. DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome. Clin. Epigenetics 11, 61 https:\/\/doi.org\/10.1186\/s13148-019-0657-6 (2019).","journal-title":"Clin. Epigenetics"},{"key":"1625_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.111950","volume":"573","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. HDAC1 participates in polycystic ovary syndrome through histone modification by regulating H19\/miR-29a-3p\/NLRP3-mediated granulosa cell pyroptosis. Mol. Cell. Endocrinol. 573, 111950 https:\/\/doi.org\/10.1016\/j.mce.2023.111950 (2023).","journal-title":"Mol. Cell. Endocrinol."},{"key":"1625_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/biolre\/ioaa007","volume":"102","author":"N Sinha","year":"2020","unstructured":"Sinha, N. et al. Developmental programming: prenatal testosterone-induced epigenetic modulation and its effect on gene expression in sheep ovary. Biol. Reprod. 102, 1045\u20131054 https:\/\/doi.org\/10.1093\/biolre\/ioaa007 (2020).","journal-title":"Biol. Reprod"},{"key":"1625_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2023.100764","volume":"23","author":"Z Zhou","year":"2023","unstructured":"Zhou, Z. et al. LINC00092 derived from follicular fluid alleviated the symptoms of PCOS through inactivation of phosphatase and tensin homolog by recruiting KDM5A. Reprod. Biol. 23, 100764 https:\/\/doi.org\/10.1016\/j.repbio.2023.100764 (2023).","journal-title":"Reprod. Biol."},{"key":"1625_CR14","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/JOE-20-0578","volume":"249","author":"I Salinas","year":"2021","unstructured":"Salinas, I., Sinha, N. & Sen, A. Androgen-induced epigenetic modulations in the ovary. J. Endocrinol. 249, R53\u2013R64 https:\/\/doi.org\/10.1530\/JOE-20-0578 (2021).","journal-title":"J. Endocrinol."},{"key":"1625_CR15","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1210\/en.2019-00389","volume":"160","author":"X Guo","year":"2019","unstructured":"Guo, X., Puttabyatappa, M., Thompson, R. C. & Padmanabhan, V. Developmental programming: contribution of epigenetic enzymes to antral follicular defects in the sheep model of PCOS. Endocrinology 160, 2471\u20132484 https:\/\/doi.org\/10.1210\/en.2019-00389 (2019).","journal-title":"Endocrinology"},{"key":"1625_CR16","doi-asserted-by":"publisher","first-page":"e1009483","DOI":"10.1371\/journal.pgen.1009483","volume":"17","author":"S Roy","year":"2021","unstructured":"Roy, S., Huang, B., Sinha, N., Wang, J. & Sen, A. Androgens regulate ovarian gene expression by balancing Ezh2-Jmjd3 mediated H3K27me3 dynamics. PLoS Genet. 17, e1009483 https:\/\/doi.org\/10.1371\/journal.pgen.1009483 (2021).","journal-title":"PLoS Genet."},{"key":"1625_CR17","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1210\/en.2017-00145","volume":"158","author":"X Ma","year":"2017","unstructured":"Ma, X. et al. Androgens regulate ovarian gene expression through modulation of Ezh2 expression and activity. Endocrinology 158, 2944\u20132954 https:\/\/doi.org\/10.1210\/en.2017-00145 (2017).","journal-title":"Endocrinology"},{"key":"1625_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41392-020-00349-7","volume":"5","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduct. Target Ther. 5, 280 https:\/\/doi.org\/10.1038\/s41392-020-00349-7 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"1625_CR19","doi-asserted-by":"publisher","first-page":"18713","DOI":"10.1039\/c9ra01561b","volume":"9","author":"S Tao","year":"2019","unstructured":"Tao, S. et al. Analysis of serum metabolomics among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls. RSC Adv. 9, 18713\u201318719 https:\/\/doi.org\/10.1039\/c9ra01561b (2019).","journal-title":"RSC Adv."},{"key":"1625_CR20","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00726-017-2494-2","volume":"49","author":"Y Martinez","year":"2017","unstructured":"Martinez, Y. et al. The role of methionine on metabolism, oxidative stress, and diseases. Amino Acids 49, 2091\u20132098 https:\/\/doi.org\/10.1007\/s00726-017-2494-2 (2017).","journal-title":"Amino Acids"},{"key":"1625_CR21","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1523-1755.2002.kid558.x","volume":"62","author":"H Kumagai","year":"2002","unstructured":"Kumagai, H. et al. Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney Int. 62, 1219\u20131228 https:\/\/doi.org\/10.1111\/j.1523-1755.2002.kid558.x (2002).","journal-title":"Kidney Int."},{"key":"1625_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.rbmo.2021.11.012","volume":"44","author":"Z Ye","year":"2022","unstructured":"Ye, Z. et al. Amino acid signatures in relation to polycystic ovary syndrome and increased risk of different metabolic disturbances. Reprod. Biomed. Online 44, 737\u2013746 https:\/\/doi.org\/10.1016\/j.rbmo.2021.11.012 (2022).","journal-title":"Reprod. Biomed. Online"},{"key":"1625_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fendo.2019.00116","volume":"10","author":"A Halama","year":"2019","unstructured":"Halama, A. et al. Metabolomics of dynamic changes in insulin resistance before and after exercise in PCOS. Front. Endocrinol. 10, 116 https:\/\/doi.org\/10.3389\/fendo.2019.00116 (2019).","journal-title":"Front. Endocrinol."},{"key":"1625_CR24","doi-asserted-by":"publisher","first-page":"e0187427","DOI":"10.1371\/journal.pone.0187427","volume":"12","author":"L Lei","year":"2017","unstructured":"Lei, L. et al. Attenuated expression of MTR in both prenatally androgenized mice and women with the hyperandrogenic phenotype of PCOS. PLoS ONE 12, e0187427 https:\/\/doi.org\/10.1371\/journal.pone.0187427 (2017).","journal-title":"PLoS ONE"},{"key":"1625_CR25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","volume":"33","author":"NEH Mimouni","year":"2021","unstructured":"Mimouni, N. E. H. et al. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab. 33, 513\u2013530 e518 https:\/\/doi.org\/10.1016\/j.cmet.2021.01.004 (2021).","journal-title":"Cell Metab."},{"key":"1625_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1210\/en.2017-00039","volume":"158","author":"X Qi","year":"2017","unstructured":"Qi, X. et al. Hyperhomocysteinemia promotes insulin resistance and adipose tissue inflammation in PCOS mice through modulating M2 macrophage polarization via estrogen suppression. Endocrinology 158, 1181\u20131193 https:\/\/doi.org\/10.1210\/en.2017-00039 (2017).","journal-title":"Endocrinology"},{"key":"1625_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/biolre\/ioab078","volume":"105","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. NAD+ deficiency and mitochondrial dysfunction in granulosa cells of women with polycystic ovary syndromedouble dagger. Biol. Reprod. 105, 371\u2013380 https:\/\/doi.org\/10.1093\/biolre\/ioab078 (2021).","journal-title":"Biol. Reprod."},{"key":"1625_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-025-01596-4","volume":"18","author":"Z Zhu","year":"2025","unstructured":"Zhu, Z. et al. Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model. J. Ovarian Res. 18, 9 https:\/\/doi.org\/10.1186\/s13048-025-01596-4 (2025).","journal-title":"J. Ovarian Res."},{"key":"1625_CR29","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/biology13121028","volume":"13","author":"C Ren","year":"2024","unstructured":"Ren, C. et al. Nicotinamide mononucleotide alleviates bile acid metabolism and hormonal dysregulation in letrozole-induced PCOS mice. Biology 13, 1028 (2024).","journal-title":"Biology"},{"key":"1625_CR30","doi-asserted-by":"publisher","first-page":"109093","DOI":"10.1016\/j.cbi.2020.109093","volume":"324","author":"HR Nejabati","year":"2020","unstructured":"Nejabati, H. R. et al. Nicotinamide and its metabolite N1-methylnicotinamide alleviate endocrine and metabolic abnormalities in adipose and ovarian tissues in rat model of polycystic ovary syndrome. Chem. Biol. Interact. 324, 109093 https:\/\/doi.org\/10.1016\/j.cbi.2020.109093 (2020).","journal-title":"Chem. Biol. Interact."},{"key":"1625_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101165","volume":"45","author":"A Roberti","year":"2021","unstructured":"Roberti, A., Fernandez, A. F. & Fraga, M. F. Nicotinamide N-methyltransferase: at the crossroads between cellular metabolism and epigenetic regulation. Mol. Metab. 45, 101165 https:\/\/doi.org\/10.1016\/j.molmet.2021.101165 (2021).","journal-title":"Mol. Metab."},{"key":"1625_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117790","volume":"295","author":"SZ Bi","year":"2025","unstructured":"Bi, S. Z. et al. Nicotinamide N-methyltransferase in cardiovascular diseases: mechanistic insights and therapeutic potential. Eur. J. Med. Chem. 295, 117790 https:\/\/doi.org\/10.1016\/j.ejmech.2025.117790 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"1625_CR33","doi-asserted-by":"publisher","unstructured":"Lai, S. Y. et al. Nicotinamide N-methyltransferase (NNMT) and liver cancer: from metabolic networks to therapeutic targets. Biomolecules 15 (2025) https:\/\/doi.org\/10.3390\/biom15050719","DOI":"10.3390\/biom15050719"},{"key":"1625_CR34","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","volume":"569","author":"MA Eckert","year":"2019","unstructured":"Eckert, M. A. et al. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature 569, 723\u2013728 https:\/\/doi.org\/10.1038\/s41586-019-1173-8 (2019).","journal-title":"Nature"},{"key":"1625_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2020.04.038","volume":"73","author":"Q Song","year":"2020","unstructured":"Song, Q. et al. ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development. J. Hepatol. 73, 783\u2013793 https:\/\/doi.org\/10.1016\/j.jhep.2020.04.038 (2020).","journal-title":"J. Hepatol."},{"key":"1625_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113208","volume":"142","author":"WD Sun","year":"2024","unstructured":"Sun, W. D. et al. Nicotinamide N-methyltransferase (NNMT): a key enzyme in cancer metabolism and therapeutic target. Int. Immunopharmacol. 142, 113208 https:\/\/doi.org\/10.1016\/j.intimp.2024.113208 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"1625_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1410479","volume":"15","author":"WD Sun","year":"2024","unstructured":"Sun, W. D. et al. Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome. Front. Pharmacol. 15, 1410479 https:\/\/doi.org\/10.3389\/fphar.2024.1410479 (2024).","journal-title":"Front. Pharmacol."},{"key":"1625_CR38","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jhep.2022.03.021","volume":"77","author":"D Li","year":"2022","unstructured":"Li, D., Yi, C., Huang, H., Li, J. & Hong, S. Hepatocyte-specific depletion of Nnmt protects mice from non-alcoholic steatohepatitis. J. Hepatol. 77, 882\u2013884 https:\/\/doi.org\/10.1016\/j.jhep.2022.03.021 (2022).","journal-title":"J. Hepatol."},{"key":"1625_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109548","volume":"125","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. Metabolome implies increased fatty acid utilization and histone methylation in the follicles from hyperandrogenic PCOS women. J. Nutr. Biochem. 125, 109548 https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109548 (2024).","journal-title":"J. Nutr. Biochem."},{"key":"1625_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep10132","volume":"5","author":"SS Udhane","year":"2015","unstructured":"Udhane, S. S., Pandey, A. V., Hofer, G., Mullis, P. E. & Fluck, C. E. Retinoic acid receptor \u03b2 and angiopoietin-like protein 1 are involved in the regulation of human androgen biosynthesis. Sci. Rep. 5, 10132 https:\/\/doi.org\/10.1038\/srep10132 (2015).","journal-title":"Sci. Rep."},{"key":"1625_CR41","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1210\/me.2014-1042","volume":"28","author":"N Xu","year":"2014","unstructured":"Xu, N., Chua, A. K., Jiang, H., Liu, N. A. & Goodarzi, M. O. Early embryonic androgen exposure induces transgenerational epigenetic and metabolic changes. Mol. Endocrinol. 28, 1329\u20131336 https:\/\/doi.org\/10.1210\/me.2014-1042 (2014).","journal-title":"Mol. Endocrinol."},{"key":"1625_CR42","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.ajpath.2024.08.012","volume":"194","author":"X Tong","year":"2024","unstructured":"Tong, X. et al. Testosterone-induced H3K27 deacetylation participates in granulosa cell proliferation suppression and pathogenesis of polycystic ovary syndrome. Am. J. Pathol. 194, 2326\u20132340 https:\/\/doi.org\/10.1016\/j.ajpath.2024.08.012 (2024).","journal-title":"Am. J. Pathol."},{"key":"1625_CR43","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41574-021-00517-x","volume":"17","author":"E Stener-Victorin","year":"2021","unstructured":"Stener-Victorin, E. & Deng, Q. Epigenetic inheritance of polycystic ovary syndrome\u2014challenges and opportunities for treatment. Nat. Rev. Endocrinol. 17, 521\u2013533 https:\/\/doi.org\/10.1038\/s41574-021-00517-x (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1625_CR44","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s43587-024-00674-4","volume":"4","author":"F Wei","year":"2024","unstructured":"Wei, F. et al. Separation of reproductive decline from lifespan extension during methionine restriction. Nat. Aging 4, 1089\u20131101 https:\/\/doi.org\/10.1038\/s43587-024-00674-4 (2024).","journal-title":"Nat. Aging"},{"key":"1625_CR45","doi-asserted-by":"publisher","first-page":"e11110","DOI":"10.7759\/cureus.11110","volume":"12","author":"V Kondapaneni","year":"2020","unstructured":"Kondapaneni, V. et al. Significance of homocysteine levels in the management of polycystic ovarian syndrome: a literature review. Cureus 12, e11110 https:\/\/doi.org\/10.7759\/cureus.11110 (2020).","journal-title":"Cureus"},{"key":"1625_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101322","volume":"28","author":"W Shen","year":"2020","unstructured":"Shen, W. et al. Homocysteine-methionine cycle is a metabolic sensor system controlling methylation-regulated pathological signaling. Redox Biol. 28, 101322 https:\/\/doi.org\/10.1016\/j.redox.2019.101322 (2020).","journal-title":"Redox Biol"},{"key":"1625_CR47","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1080\/21655979.2022.2066608","volume":"13","author":"T Li","year":"2022","unstructured":"Li, T. et al. Increased homocysteine regulated by androgen activates autophagy by suppressing the mammalian target of rapamycin pathway in the granulosa cells of polycystic ovary syndrome mice. Bioengineered 13, 10875\u201310888 https:\/\/doi.org\/10.1080\/21655979.2022.2066608 (2022).","journal-title":"Bioengineered"},{"key":"1625_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111241","volume":"27","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Effects of hyperhomocysteinemia on follicular development and oocytes quality. iScience 27, 111241 https:\/\/doi.org\/10.1016\/j.isci.2024.111241 (2024).","journal-title":"iScience"},{"key":"1625_CR49","doi-asserted-by":"publisher","first-page":"10631","DOI":"10.26355\/eurrev_202311_34343","volume":"27","author":"AH Alfeel","year":"2023","unstructured":"Alfeel, A. H. et al. Association between oxidative stress, antioxidant enzymes, and homocysteine in patients with polycystic ovary syndrome. Eur. Rev. Med. Pharmacol. Sci. 27, 10631\u201310641 https:\/\/doi.org\/10.26355\/eurrev_202311_34343 (2023).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"1625_CR50","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ajpath.2024.02.003","volume":"194","author":"P Cao","year":"2024","unstructured":"Cao, P. et al. DNA hypomethylation-mediated transcription dysregulation participates in pathogenesis of polycystic ovary syndrome. Am. J. Pathol. 194, 894\u2013911 https:\/\/doi.org\/10.1016\/j.ajpath.2024.02.003 (2024).","journal-title":"Am. J. Pathol."},{"key":"1625_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/abr.abr_144_20","volume":"9","author":"F Fazel Torshizi","year":"2020","unstructured":"Fazel Torshizi, F. et al. The effects of zinc methionine on reproductive and thyroid hormones in rats with polycystic ovarian syndrome. Adv. Biomed. Res. 9, 57 https:\/\/doi.org\/10.4103\/abr.abr_144_20 (2020).","journal-title":"Adv. Biomed. Res."},{"key":"1625_CR52","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/procel\/pwad065","volume":"15","author":"KH Zhang","year":"2024","unstructured":"Zhang, K. H. et al. Follicle stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulation. Protein Cell 15, 512\u2013529 https:\/\/doi.org\/10.1093\/procel\/pwad065 (2024).","journal-title":"Protein Cell"},{"key":"1625_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104492","volume":"89","author":"L Mu","year":"2023","unstructured":"Mu, L. et al. PPM1K-regulated impaired catabolism of branched-chain amino acids orchestrates polycystic ovary syndrome. eBioMedicine 89, 104492 https:\/\/doi.org\/10.1016\/j.ebiom.2023.104492 (2023).","journal-title":"eBioMedicine"},{"key":"1625_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2025.156238","volume":"168","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. L-Kynurenine activates the AHR-PCSK9 pathway to mediate the lipid metabolic and ovarian dysfunction in polycystic ovary syndrome. Metabolism 168, 156238 https:\/\/doi.org\/10.1016\/j.metabol.2025.156238 (2025).","journal-title":"Metabolism"},{"key":"1625_CR55","doi-asserted-by":"publisher","unstructured":"Turathum, B., Gao, E. M. & Chian, R. C. The function of cumulus cells in oocyte growth and maturation and in subsequent ovulation and fertilization. Cells 10, 2292 (2021) https:\/\/doi.org\/10.3390\/cells10092292","DOI":"10.3390\/cells10092292"},{"key":"1625_CR56","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/molehr\/gaq031","volume":"16","author":"Z Huang","year":"2010","unstructured":"Huang, Z. & Wells, D. The human oocyte and cumulus cells relationship: new insights from the cumulus cell transcriptome. Mol. Hum. Reprod. 16, 715\u2013725 https:\/\/doi.org\/10.1093\/molehr\/gaq031 (2010).","journal-title":"Mol. Hum. Reprod."},{"key":"1625_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","volume":"18","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis, E., Papavassiliou, A. G., Kandarakis, S. A. & Chrousos, G. P. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol. Metab. 18, 280\u2013285 https:\/\/doi.org\/10.1016\/j.tem.2007.07.004 (2007).","journal-title":"Trends Endocrinol. Metab."},{"key":"1625_CR58","doi-asserted-by":"publisher","unstructured":"Rudnicka, E. et al. Chronic low grade inflammation in pathogenesis of PCOS. Int. J. Mol. Sci. 22, 3789 (2021) https:\/\/doi.org\/10.3390\/ijms22073789","DOI":"10.3390\/ijms22073789"},{"key":"1625_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1169232","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang, J., Yin, T. & Liu, S. Dysregulation of immune response in PCOS organ system. Front. Immunol. 14, 1169232 https:\/\/doi.org\/10.3389\/fimmu.2023.1169232 (2023).","journal-title":"Front. Immunol"},{"key":"1625_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.10.038","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. Genetic associations of metabolic factors and therapeutic drug targets with polycystic ovary syndrome. J. Adv. Res. https:\/\/doi.org\/10.1016\/j.jare.2024.10.038 (2024).","journal-title":"J. Adv. Res."},{"key":"1625_CR61","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tem.2014.12.003","volume":"26","author":"LJ Moran","year":"2015","unstructured":"Moran, L. J., Norman, R. J. & Teede, H. J. Metabolic risk in PCOS: phenotype and adiposity impact. Trends Endocrinol. Metab. 26, 136\u2013143 https:\/\/doi.org\/10.1016\/j.tem.2014.12.003 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"1625_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","volume":"86","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis, P., Tarlatzis, B. C. & Kauffman, R. P. Polycystic ovarian syndrome (PCOS): long-term metabolic consequences. Metabolism 86, 33\u201343 https:\/\/doi.org\/10.1016\/j.metabol.2017.09.016 (2018).","journal-title":"Metabolism"},{"key":"1625_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2025.109665","volume":"222","author":"H Lan","year":"2025","unstructured":"Lan, H. et al. Targeted metabolomics in PCOS mice identifies hippuric acid as a therapeutic metabolite. Steroids 222, 109665 https:\/\/doi.org\/10.1016\/j.steroids.2025.109665 (2025).","journal-title":"Steroids"},{"key":"1625_CR64","doi-asserted-by":"publisher","first-page":"e21417","DOI":"10.1371\/journal.pone.0021417","volume":"6","author":"N Putluri","year":"2011","unstructured":"Putluri, N. et al. Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells. PLoS ONE 6, e21417 https:\/\/doi.org\/10.1371\/journal.pone.0021417 (2011).","journal-title":"PLoS ONE"},{"key":"1625_CR65","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nchembio.1204","volume":"9","author":"OA Ulanovskaya","year":"2013","unstructured":"Ulanovskaya, O. A., Zuhl, A. M. & Cravatt, B. F. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat. Chem. Biol. 9, 300\u2013306 https:\/\/doi.org\/10.1038\/nchembio.1204 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"1625_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1150-z","volume":"21","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Breast Cancer Res. 21, 64 https:\/\/doi.org\/10.1186\/s13058-019-1150-z (2019).","journal-title":"Breast Cancer Res."},{"key":"1625_CR67","doi-asserted-by":"publisher","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","volume":"14","author":"F Day","year":"2018","unstructured":"Day, F. et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 14, e1007813 https:\/\/doi.org\/10.1371\/journal.pgen.1007813 (2018).","journal-title":"PLoS Genet."},{"key":"1625_CR68","doi-asserted-by":"publisher","first-page":"e1003132","DOI":"10.1371\/journal.pmed.1003132","volume":"17","author":"M Dapas","year":"2020","unstructured":"Dapas, M. et al. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis. PLoS Med. 17, e1003132 https:\/\/doi.org\/10.1371\/journal.pmed.1003132 (2020).","journal-title":"PLoS Med."},{"key":"1625_CR69","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.2384","volume":"44","author":"Y Shi","year":"2012","unstructured":"Shi, Y. et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat. Genet. 44, 1020\u20131025 https:\/\/doi.org\/10.1038\/ng.2384 (2012).","journal-title":"Nat. Genet."},{"key":"1625_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng.732","volume":"43","author":"ZJ Chen","year":"2011","unstructured":"Chen, Z. J. et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat. Genet. 43, 55\u201359 https:\/\/doi.org\/10.1038\/ng.732 (2011).","journal-title":"Nat. Genet."},{"key":"1625_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.762177","volume":"12","author":"R Azumah","year":"2021","unstructured":"Azumah, R. et al. Analysis of upstream regulators, networks, and pathways associated with the expression patterns of polycystic ovary syndrome candidate genes during fetal ovary development. Front. Genet. 12, 762177 https:\/\/doi.org\/10.3389\/fgene.2021.762177 (2021).","journal-title":"Front. Genet"},{"key":"1625_CR72","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/humrep\/deab250","volume":"37","author":"JS Tyrmi","year":"2022","unstructured":"Tyrmi, J. S. et al. Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome. Hum. Reprod. 37, 352\u2013365 https:\/\/doi.org\/10.1093\/humrep\/deab250 (2022).","journal-title":"Hum. Reprod."},{"key":"1625_CR73","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1016\/j.celrep.2019.07.088","volume":"28","author":"S Bianco","year":"2019","unstructured":"Bianco, S. et al. The ovulatory signal precipitates LRH-1 transcriptional switching mediated by differential chromatin accessibility. Cell Rep. 28, 2443\u20132454 e2444 https:\/\/doi.org\/10.1016\/j.celrep.2019.07.088 (2019).","journal-title":"Cell Rep."},{"key":"1625_CR74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bcp.2017.11.007","volume":"147","author":"H Neelakantan","year":"2018","unstructured":"Neelakantan, H. et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem. Pharmacol. 147, 141\u2013152 https:\/\/doi.org\/10.1016\/j.bcp.2017.11.007 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"1625_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85051-6","volume":"11","author":"CM Sampson","year":"2021","unstructured":"Sampson, C. M. et al. Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese mice. Sci Rep. 11, 5637 https:\/\/doi.org\/10.1038\/s41598-021-85051-6 (2021).","journal-title":"Sci Rep."},{"key":"1625_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19634-2","volume":"12","author":"S Ruf","year":"2022","unstructured":"Ruf, S. et al. Novel tricyclic small molecule inhibitors of nicotinamide N-methyltransferase for the treatment of metabolic disorders. Sci. Rep. 12, 15440 https:\/\/doi.org\/10.1038\/s41598-022-19634-2 (2022).","journal-title":"Sci. Rep."},{"key":"1625_CR77","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE","year":"2004","unstructured":"The Rotterdam ESHRE Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41\u201347 https:\/\/doi.org\/10.1093\/humrep\/deh098 (2004).","journal-title":"Hum. Reprod."},{"key":"1625_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"1625_CR79","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 https:\/\/doi.org\/10.1093\/bioinformatics\/btp352 (2009).","journal-title":"Bioinformatics"},{"key":"1625_CR80","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinform. 12, 323 https:\/\/doi.org\/10.1186\/1471-2105-12-323 (2011).","journal-title":"BMC Bioinform."},{"key":"1625_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"1625_CR82","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 https:\/\/doi.org\/10.1038\/nmeth.1923 (2012).","journal-title":"Nat. Methods"},{"key":"1625_CR83","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 https:\/\/doi.org\/10.1093\/bioinformatics\/btq033 (2010).","journal-title":"Bioinformatics"},{"key":"1625_CR84","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13072-019-0287-4","volume":"12","author":"MP Meers","year":"2019","unstructured":"Meers, M. P., Tenenbaum, D. & Henikoff, S. Peak calling by sparse enrichment analysis for CUT&RUN chromatin profiling. Epigenetics Chromatin 12, 42 https:\/\/doi.org\/10.1186\/s13072-019-0287-4 (2019).","journal-title":"Epigenetics Chromatin"},{"key":"1625_CR85","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1089\/cmb.2017.0096","volume":"24","author":"A Kechin","year":"2017","unstructured":"Kechin, A., Boyarskikh, U., Kel, A. & Filipenko, M. cutPrimers: a new tool for accurate cutting of primers from reads of targeted next generation sequencing. J. Comput. Biol. 24, 1138\u20131143 https:\/\/doi.org\/10.1089\/cmb.2017.0096 (2017).","journal-title":"J. Comput. Biol."},{"key":"1625_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 https:\/\/doi.org\/10.1186\/gb-2008-9-9-r137 (2008).","journal-title":"Genome Biol."},{"key":"1625_CR87","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk5382","volume":"384","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction. Science 384, eadk5382 https:\/\/doi.org\/10.1126\/science.adk5382 (2024).","journal-title":"Science"},{"key":"1625_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62951-z","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome. Nat. Commun. 16, 7611 https:\/\/doi.org\/10.1038\/s41467-025-62951-z (2025).","journal-title":"Nat. Commun."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01625-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01625-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01625-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:07:06Z","timestamp":1795100826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01625-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":88,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["1625"],"URL":"https:\/\/doi.org\/10.1038\/s42255-026-01625-6","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}